Match Placebo to Test Product, SAR441566, SAR441566 clinical trials

A Phase 2, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging study of Efficacy and Safety of SAR441566 in Adults with Moderate to Severe Plaque Psoriasis

This study is testing a new medicine called SAR441566 for moderate to severe plaque psoriasis. Researchers want to see if it helps improve psoriasis symptoms and if it's safe. It's a key step to understand if this medicine could become a future treatment option.